Human papillomavirus vaccine disease impact beyond expectations.
Journal
Current opinion in virology
ISSN: 1879-6265
Titre abrégé: Curr Opin Virol
Pays: Netherlands
ID NLM: 101560941
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
25
05
2019
revised:
11
06
2019
accepted:
12
06
2019
pubmed:
6
8
2019
medline:
5
8
2020
entrez:
6
8
2019
Statut:
ppublish
Résumé
Since 2006, 115 countries and territories have introduced human papillomavirus (HPV) vaccination programs. Several efforts have been undertaken to evaluate the impact of HPV vaccines. Many countries, mainly high-income and with high screening coverage, are already reporting a visible impact of the HPV vaccine on HPV-related diseases. Others, largely low-income and middle-income countries, are introducing HPV vaccine to control HPV diseases that will undoubtedly generate a similar impact. In this review, we will summarize the compelling evidence of the impact of vaccines in reducing the burden of HPV-related disease. The data support additional efforts to make HPV vaccines widely available to adolescent girls in the countries that bear the vast majority of cervical cancer-related morbidity and mortality.
Identifiants
pubmed: 31382121
pii: S1879-6257(19)30043-4
doi: 10.1016/j.coviro.2019.06.006
pii:
doi:
Substances chimiques
Papillomavirus Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
16-22Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.